Standard Family Office’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-24
Closed -$1K 156
2022
Q3
$1K Hold
24
﹤0.01% 447
2022
Q2
$1K Buy
+24
New +$1.28K 0.01% 196
2022
Q1
Sell
-26
Closed -$2K 140
2021
Q4
$2K Buy
+26
New +$2.29K 0.02% 190
2021
Q3
Sell
-142
Closed -$18K 230
2021
Q2
$18K Buy
142
+14
+11% +$1.67K ﹤0.01% 240
2021
Q1
$17K Buy
128
+37
+41% +$5.07K ﹤0.01% 298
2020
Q4
$12K Buy
+91
New +$11K ﹤0.01% 306

Other funds holding EXAS

Standard Family Office's EXAS Position: Q4 2022 in Review

Standard Family Office sold out of Exact Sciences (EXAS) in Q4 2022, closing a stake of 24 shares — an estimated $1K sold.

Standard Family Office first reported a position in EXAS in Q4 2020 and held it in 6 quarters. The position peaked at $18K in Q2 2021. 552 funds tracked by Wall St. Rank hold EXAS as of Q4 2022.

  • Standard Family Office reported no remaining Exact Sciences position as of Q4 2022 after selling out during the quarter.
  • Standard Family Office sold 24 Exact Sciences shares in Q4 2022, an estimated $1K.
  • Standard Family Office first reported a position in Exact Sciences in Q4 2020 and held it in 6 quarters.
  • Standard Family Office's Exact Sciences position peaked at $18K in Q2 2021.
  • 552 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2022.

Based on Standard Family Office's 13F filing for Q4 2022, filed 13 Feb 2023.